Repeated Examinations for Typing Pulmonary Embolism
Repeated Examinations for Typing Pulmonary Embolism (RE-TyPE)
- Pulmonary Embolism (Diagnosis)
- Pulmonary Embolism Acute
- Pulmonary Embolism With Acute Cor Pulmonale
- Pulmonary Embolism With Right Ventricle Enlargement
- Pulmonary Embolism (PE)
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Sahlgrenska University Hospital
- Enrolment target
- 400
- Started
- 1 April 2026
- Main results due
- 1 January 2030
- Study sites
- 3
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Adult patients (≥ 18 years old) who is diagnosed with, or followed as out-patients for, PE at Sahlgrenska University Hospital 2. Written informed consent Exclusion Criteria from Cohort A: 1. Low risk, intermediate-low risk or high risk PE\* 2. \>48 hours since PE diagnosis 3. Expected inability to comply with the protocol (e.g. dementia) Exclusion Criterium from Cohort B: 1\. Not geographically belonging to Sahlgrenska University Hospital \*If biomarkers (and/or echocardiography) are not available in hemodynamically stable patients, RV/LV-ratio \>1 will be considered as preliminary intermediate-high risk. If biomarkers later fall out negative, the patient will be considered as intermediate-low risk and will be moved to Cohort B
What this study is about
In the sponsor’s own words, from the registry.
PURPOSE
The two related purposes of the RE-TyPE study are:
1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital
HYPOTHESES
1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital
Study sites(3)
Sahlgrenska University Hospital/Mölndal
Gothenburg, Region Västra Götaland, Sweden
Not yet recruiting
Sahlgrenska University Hospital/Sahlgrenska
Gothenburg, Region Västra Götaland, Sweden
Recruiting
Sahlgrenska University Hospital/Östra
Gothenburg, Region Västra Götaland, Sweden
Not yet recruiting
Showing 3 of 3 sites. 1 of the 3 sites on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07491094. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me